Skip to content

Effect of Moringa in metabolic syndrome

The effect of Moringa oral product on inflammatory factors, insulin resistance and abdominal obesity in military with metabolic syndrome, clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230720058857N1
Enrollment
102
Registered
2023-07-31
Start date
2023-08-21
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome. E-66

Interventions

Intervention 1: Intervention group: Military patients with metabolic syndrome taking 2 grams of Moringa supplement daily for 8 weeks. Intervention 2: Control group: Military patients with metabolic sy

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 20-60 years old - no specific underlying disease (such as malignancy, kidney and liver failure) - no pregnancy or breastfeeding - no allergy to moringa food product - no smoking and alcohol consumption -Completion of the consent form and interest in participating in the study - Waist circumference above 80 cm in women and above 94 cm in men (the main criterion of IDF) - Having the criteria of metabolic syndrome (according to the International Diabetes Federation)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tumor necrosis factor-alpha. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;High sensitive C reactive protein. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Erythrocyte sedimentation rate. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Interleukin 6. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Malondialdehyde. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Insulin. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Glycated Hemoglobin. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Homeostatic Model Assessment for Insulin Resistance. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Blood sample.;Body fat percentage. Timepoint: At the beginning of the study and 8 weeks after starting the Moringa supplement. Method of measurement: Body analyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Rashidmayvan

Gonabad University of Medical Sciences

Rashidmayvan.m@gmu.ac.ir+98 51 3854 2140

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026